Ipca Laboratory P. Ltd.
Click on the API name to know their properties
|Composit uses/ indication of COLIZOLE D.S :|
Bacterial infections, Lymphogranuloma venereum, Respiratory tract infections, Urinary tract infection.
Respiratory tract infections, Gastroenteritis, Susceptible infections, Uncomplicated urinary tract infections, Pneumocystis (carinii) jiroveci pneumonia.
|Composit contra indication of COLIZOLE D.S :|
Severe renal or hepatic impairment, blood disorders, hypersensitivity to sulfonamides, porphyria, SLE, infants <2 mth, pregnancy (3rd trimester) and lactation.
Hypersensitivity, serious haematological disorders, severe renal impairment, megaloblastic anaemia secondary to folate depletion.
|Composit side effects of COLIZOLE D.S :|
Hepatic damage, Renal failure, Crystalluria, Stevens Johnson syndrome, Nausea, Vomiting, Confusion, Dizziness, Abdominal pain.Rashes, Hemolytic anemia, Thrombocytopenia, Eosinophilia, Serum sickness, Hypoprothrombinemia, Hematological disorder.
Nausea, vomiting, glossitis, pruritus, skin rash, fever, hyponatremia, hyperkalaemia, photosensitivity, liver enzyme elevation, , raised serum creatinine and BUN, blood dyscrasias, cholestatic jaundice, anaphylaxis, aseptic meningitis. Stevens-Johnson syndrome, toxic epidermal necrolysis.
|Composit caution of COLIZOLE D.S :|
Renal or hepatic impairment, history of allergy or asthma, AIDS, G6PD deficiency, elderly, ensure adequate fluid intake to reduce risk of crystalluria. Pregnancy.
Renal and hepatic impairment, porphyria, patients with potential folate deficiency, elderly, pregnancy, lactation, children with fragile X chromosome associated with mental retardation. Perform regular haematological examination.
Cadila Pharmaceuticals Limited